Ardais
Lexington
About Ardais
Ardais Corporation is a clinical genomics company, is dedicated to enhancing and accelerating biomedical research by introducing actual human disease into the pharmaceutical discovery research process. To achieve its goals, Ardais has incorporated multi-disciplinary scientific expertise into its operations, including pathology, molecular biology and genomics, statistical genomics, bioinformatics and medical informatics, as well as process management skills such as logistics, industrial engineering, and robotics. The result of this unique integration is a state-of-the-art, proprietary discovery platform that is dramatically transforming genomic research and leading the way to novel diagnostic and therapeutic solutions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $56.5M
- Funding stage: M&A
- Last round: Series C (Jan 2003)
- Website: ardais.comcorporate
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Genetics, Health Care
Canonical: https://fsome.com/organization/ardais-2676280 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.